Partf Phase News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Partf Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Partf Phase Today - Breaking & Trending Today

Antengene Announces IND Approval in China for a Phase II Study of Eltanexor (ATG-016) in Patients with High-Risk Myelodysplastic Syndromes

Published: March 30, 2022

/PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to...

Source: prnewswire.com

Related Topics:

United StatesHong KongSouth KoreaJay MeiAsia PacificPeter QianSelective Inhibitor Of Nuclear ExportKaryopharm Therapeutics IncCompany AnnualAntengene CorporationDrug AdministrationAmerican Society Of HematologyChina National Medical Products AdministrationHong Kong Stock ExchangePrnewswire Antengene Corporation LimitedAntengene Corporation LimitedCorporation LimitedAsia Pacific RegionKaryopharm TherapeuticsPartf PhaseAmerican SocietyAnnual MeetingNuclear ExportSelective InhibitorEpstein Barr Virus